Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modeling human T1D-associated autoimmune processes
Mohsen Khosravi‐Maharlooei, Rachel Madley, Chiara Borsotti, et al.
Molecular Metabolism (2021) Vol. 56, pp. 101417-101417
Open Access | Times Cited: 21

Showing 21 citing articles:

Heterogeneity and endotypes in type 1 diabetes mellitus
María J. Redondo, Noel G. Morgan
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 9, pp. 542-554
Closed Access | Times Cited: 65
Towards a better understanding of diabetes mellitus using organoid models
Belin Selcen Beydag-Tasöz, Siham Yennek, Anne Grapin‐Botton
Nature Reviews Endocrinology (2023)
Open Access | Times Cited: 43
Immunological and virological triggers of type 1 diabetes: insights and implications
Joana Lemos, Khemraj Hirani, Matthias von Herrath
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 20
The emerging role of regulatory cell-based therapy in autoimmune disease
Farbod Ghobadinezhad, Nasim Ebrahimi, Fatemeh Mozaffari, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 58
Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead
Alessandro Grattoni, Gregory S. Korbutt, Alice A. Tomei, et al.
Nature Reviews Endocrinology (2024) Vol. 21, Iss. 1, pp. 14-30
Closed Access | Times Cited: 15
Engineering synthetic suppressor T cells that execute locally targeted immunoprotective programs
Nishith R. Reddy, Hasna Maachi, Yini Xiao, et al.
Science (2024) Vol. 386, Iss. 6726
Closed Access | Times Cited: 8
Immunological balance between Treg and Th17 lymphocytes as a key element of type 1 diabetes progression in children
Aleksandra Starosz, Milena Jamiołkowska, Barbara Głowińska‐Olszewska, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 20
Mesenchymal Stem Cell-Derived Extracellular Vesicles as Non-Coding RNA Therapeutic Vehicles in Autoimmune Diseases
Olga Martínez-Arroyo, Ana Ortega, María José Forner, et al.
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 733-733
Open Access | Times Cited: 19
Role of USP7 in the regulation of tolerogenic dendritic cell function in type 1 diabetes
Farhan Ullah Khan, Puregmaa Khongorzul, Denis Gris, et al.
Cellular & Molecular Biology Letters (2025) Vol. 30, Iss. 1
Open Access
Revolutionizing type 1 diabetes management: Exploring oral insulin and adjunctive treatments
Mohsen Nabi‐Afjadi, S. Ostadhadi, Mahsa Liaghat, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116808-116808
Open Access | Times Cited: 3
Anti-CD3 monoclonal antibodies for the prevention and treatment of type 1 diabetes: A literature review
James LeFevre, Sneha L Cyriac, Adna Tokmic, et al.
American Journal of Health-System Pharmacy (2022) Vol. 79, Iss. 23, pp. 2099-2117
Closed Access | Times Cited: 16
Epitope-based precision immunotherapy of Type 1 diabetes
Rebuma Firdessa Fite, Camillo Bechi Genzano, Roberto Mallone, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 7
Interleukin 35: protective role and mechanism in type 1 diabetes
Si‐Ming Zhang, Jun Liang, Jiping Xia, et al.
Central European Journal of Immunology (2023) Vol. 48, Iss. 1, pp. 48-53
Open Access | Times Cited: 7
Stem cell-based multi-tissue platforms to model human autoimmune diabetes
Karla F. Leavens, Juan R. Alvarez‐Dominguez, Linda T. Vo, et al.
Molecular Metabolism (2022) Vol. 66, pp. 101610-101610
Open Access | Times Cited: 12
Molecular profiling of NOD mouse islets reveals a novel regulator of insulitis onset
Andreas Frøslev Mathisen, Andrei M. Vacaru, Lucas Unger, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Modelling Graft-Versus-Host Disease in Mice Using Human Peripheral Blood Mononuclear Cells
Manjurul Haque, Dominic A. Boardman, Avery J. Lam, et al.
BIO-PROTOCOL (2022) Vol. 12, Iss. 23
Open Access | Times Cited: 8
Untangling the genetics of beta cell dysfunction and death in type 1 diabetes
Catherine C. Robertson, Ruth M. Elgamal, Belle A. Henry-Kanarek, et al.
Molecular Metabolism (2024) Vol. 86, pp. 101973-101973
Open Access | Times Cited: 1
Selected Serum Markers Associated with Pathogenesis and Clinical Course of Type 1 Diabetes in Pediatric Patients—The Effect of Disease Duration
Agnieszka Ochocińska, Marta Wysocka‐Mincewicz, J Swiderska, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 6, pp. 2151-2151
Open Access | Times Cited: 3
Targeted Animal Models for Preclinical Assessment of Cellular and Gene Therapies in Pancreatic and Liver Diseases: Regulatory and Practical Insights
Hongjun Wang, Rachele Ciccocioppo, Shuji Terai, et al.
Cytotherapy (2024)
Closed Access
The role of animal models in the treatment of diabetes mellitus
Siqi Zhang
(2023), pp. 93-93
Closed Access
Primary understanding of type 1 diabetes as an autoimmune disease
Mohamd A. Alblihed
Saudi Journal for Health Sciences (2022) Vol. 11, Iss. 3, pp. 165-169
Open Access
Page 1

Scroll to top